Testicular cancer follow-up costs in Germany from 2000 to 2015

Advances in testicular cancer screening and therapy increased 10-year survival to 97% despite a rising incidence; eventually expanding the population of survivors requiring follow-up. We analyzed 10-year follow-up costs after testicular cancer treatment in Germany during 2000, 2008, and 2015.

Saved in:
Bibliographic Details
Main Authors: Michaeli, Christoph T. (Author) , Michaeli, Julia (Author) , Michaeli, Daniel (Author)
Format: Article (Journal)
Language:English
Published: 22 April 2021
In: Journal of cancer research and clinical oncology
Year: 2021, Volume: 147, Issue: 8, Pages: 2249-2258
ISSN:1432-1335
DOI:10.1007/s00432-021-03643-1
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-021-03643-1
Get full text
Author Notes:Thomas Michaeli, Julia Michaeli, Daniel Michaeli
Description
Summary:Advances in testicular cancer screening and therapy increased 10-year survival to 97% despite a rising incidence; eventually expanding the population of survivors requiring follow-up. We analyzed 10-year follow-up costs after testicular cancer treatment in Germany during 2000, 2008, and 2015.
Item Description:Gesehen am 25.01.2023
Physical Description:Online Resource
ISSN:1432-1335
DOI:10.1007/s00432-021-03643-1